In summary, COMMD4 depletion resulted in the NSCLC cells undergoing mitotic catastrophe and apoptosis, suggesting that COMMD4 is a good therapeutic target for the treatment of NSCLC. The gene discussed is COMMD4; the disease is non-small cell lung carcinoma.